Multiple Sclerosis Clinical Trial

A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1

Summary

The primary objective of this study is to evaluate the long-term safety and tolerability of ALKS 8700 for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS). The secondary objective of this study is to evaluate treatment effect over time in adult participants with RRMS treated with ALKS 8700.

View Eligibility Criteria

Eligibility Criteria

Key Inclusion Criteria:

Has a confirmed diagnosis of RRMS
Neurologically stable with no evidence of relapse within 30 days prior to Visit 2

Exclusion Criteria:

Subject is pregnant or breastfeeding or plans to become pregnant or begin breastfeeding at any point during the study and for 30 days after any study drug administration
Diagnosis of primary progressive, secondary progressive, or progressive relapsing MS
History of clinically significant cardiovascular, pulmonary, gastrointestinal, dermatologic, psychiatric, neurologic (other than MS), and/or other major disease that would preclude participation in a clinical trial
History of a myocardial infarction, including a silent myocardial infarction identified on ECG, or unstable angina

NOTE: Other protocol defined Includison/Exclusion criteria may apply.

Study is for people with:

Multiple Sclerosis

Phase:

Phase 3

Estimated Enrollment:

1057

Study ID:

NCT02634307

Recruitment Status:

Completed

Sponsor:

Biogen

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 115 Locations for this study

See Locations Near You

Alkermes Investigational Site
Cullman Alabama, 35058, United States
Alkermes Investigational Site
Phoenix Arizona, 85004, United States
Alkermes Investigational Site
Phoenix Arizona, 85018, United States
Alkermes Investigational Site
Phoenix Arizona, 85032, United States
Alkermes Investigational Site
Tucson Arizona, 85704, United States
Alkermes Investigational Site
Berkeley California, 94705, United States
Alkermes Investigational Site
Loma Linda California, 92354, United States
Alkermes Investigational Site
Long Beach California, 90806, United States
Alkermes Investigational Site
San Diego California, 92103, United States
Alkermes Investigational Site
Basalt Colorado, 81621, United States
Alkermes Investigational Site
Centennial Colorado, 80111, United States
Alkermes Investigational Site
Denver Colorado, 80209, United States
Alkermes Investigational Site
Middlebury Connecticut, 06762, United States
Alkermes Investigational Site
Stamford Connecticut, 06905, United States
Alkermes Investigational Site
Washington District of Columbia, 20007, United States
Alkermes Investigational Site
Atlantis Florida, 33462, United States
Alkermes Investigational Site
Bradenton Florida, 34209, United States
Alkermes Investigational Site
Jacksonville Florida, 32209, United States
Alkermes Investigational Site
Maitland Florida, 32751, United States
Alkermes Investigational Site
Naples Florida, 34102, United States
Alkermes Investigational Site
Ormond Beach Florida, 32174, United States
Alkermes Investigational Site
Sarasota Florida, 34239, United States
Alkermes Investigational Site
Tampa Florida, 33634, United States
Alkermes Investigational Site
Vero Beach Florida, 32960, United States
Alkermes Investigational Site
Atlanta Georgia, 30312, United States
Alkermes Investigational Site
Atlanta Georgia, 30327, United States
Alkermes Investigational Site
Atlanta Georgia, 30342, United States
Alkermes Investigational Site
Columbus Georgia, 31904, United States
Alkermes Investigational Site
Evanston Illinois, 60201, United States
Alkermes Investigational Site
Indianapolis Indiana, 46202, United States
Alkermes Investigational Site
Indianapolis Indiana, 46260, United States
Alkermes Investigational Site
Des Moines Iowa, 50314, United States
Alkermes Investigational Site
Overland Park Kansas, 66213, United States
Alkermes Investigational Site
Lexington Kentucky, 40513, United States
Alkermes Investigational Site
Alexandria Louisiana, 71301, United States
Alkermes Investigational Site
Baton Rouge Louisiana, 70810, United States
Alkermes Investigational Site
Detroit Michigan, 48202, United States
Alkermes Investigational Site
Traverse City Michigan, 49684, United States
Alkermes Investigational Site
Golden Valley Minnesota, 55422, United States
Alkermes Investigational Site
Saint Louis Missouri, 63104, United States
Alkermes Investigational Site
Saint Louis Missouri, 63110, United States
Alkermes Investigational Site
Saint Louis Missouri, 63131, United States
Alkermes Investigational Site
Albuquerque New Mexico, 87106, United States
Alkermes Investigational Site
Patchogue New York, 11772, United States
Alkermes Investigational Site
Plainview New York, 11803, United States
Alkermes Investigational Site
Stony Brook New York, 11794, United States
Alkermes Investigational Site
Syracuse New York, 13210, United States
Alkermes Investigational Site
Charlotte North Carolina, 28203, United States
Alkermes Investigational Site
Greensboro North Carolina, 27405, United States
Alkermes Investigational Site
Raleigh North Carolina, 27607, United States
Alkermes Investigational Site
Winston-Salem North Carolina, 27103, United States
Alkermes Investigational Site
Canton Ohio, 44718, United States
Alkermes Investigational Site
Columbus Ohio, 43210, United States
Alkermes Investigational Site
Dayton Ohio, 45417, United States
Alkermes Investigational Site
Oklahoma City Oklahoma, 73104, United States
Alkermes Investigational Site
Medford Oregon, 97504, United States
Alkermes Investigational Site
Philadelphia Pennsylvania, 19107, United States
Alkermes Investigational Site
Charleston South Carolina, 29406, United States
Alkermes Investigational Site
Greer South Carolina, 29650, United States
Alkermes Investigational Site
Rock Hill South Carolina, 29732, United States
Alkermes Investigational Site
Spartanburg South Carolina, 29307, United States
Alkermes Investigational Site
Cordova Tennessee, 38018, United States
Alkermes Investigational Site
Franklin Tennessee, 37064, United States
Alkermes Investigational Site
Knoxville Tennessee, 37922, United States
Alkermes Investigational Site
Dallas Texas, 75231, United States
Alkermes Investigational Site
Houston Texas, 77030, United States
Alkermes Investigational Site
Houston Texas, 77074, United States
Alkermes Investigational Site
Lubbock Texas, 79410, United States
Alkermes Investigational Site
Salt Lake City Utah, 84103, United States
Alkermes Investigational Site
Newport News Virginia, 23601, United States
Alkermes Investigational Site
Richmond Virginia, 23228, United States
Alkermes Investigational Site
Seattle Washington, 98101, United States
Alkermes Investigational Site
Seattle Washington, 98122, United States
Alkermes Investigational Site
Seattle Washington, 98133, United States
Alkermes Investigational Site
Brugge , 8000, Belgium
Alkermes Investigational Site
Fraiture , 4557, Belgium
Alkermes Investigational Site
La Louviere , 7100, Belgium
Alkermes Investigational Site
Blagoevgrad , 2700, Bulgaria
Alkermes Investigational Site
Pleven , 5800, Bulgaria
Alkermes Investigational Site
Sofia , 1309, Bulgaria
Alkermes Investigational Site
Sofia , 1606, Bulgaria
Alkermes Investigational Site
Sofia , 1797, Bulgaria
Alkermes Investigational Site
Gatineau Quebec, J8Y 1, Canada
Alkermes Investigational Site
Berlin , 10713, Germany
Alkermes Investigational Site
Berlin , 12099, Germany
Alkermes Investigational Site
Dresden , 01307, Germany
Alkermes Investigational Site
Leipzig , 4103, Germany
Alkermes Investigational Site
Ulm , 89073, Germany
Alkermes Investigational Site
Ulm , 89081, Germany
Alkermes Investigational Site
Westerstede , 26655, Germany
Alkermes Investigational Site
Gdansk , 80-80, Poland
Alkermes Investigational Site
Katowice , 40-12, Poland
Alkermes Investigational Site
Katowice , 40-64, Poland
Alkermes Investigational Site
Kielce , 25-72, Poland
Alkermes Investigational Site
Krakow , 31-50, Poland
Alkermes Investigational Site
Lodz , 90-32, Poland
Alkermes Investigational Site
Lublin , 20-71, Poland
Alkermes Investigational Site
Plewiska , 62-06, Poland
Alkermes Investigational Site
Szczecin , 70-11, Poland
Alkermes Investigational Site
Krasnoyarsk , 66037, Russian Federation
Alkermes Investigational Site
Nizhniy Novgorod , 60315, Russian Federation
Alkermes Investigational Site
Belgrade , 11000, Serbia
Alkermes Investigational Site
Kragujevac , 34000, Serbia
Alkermes Investigational Site
Nis , 18000, Serbia
Alkermes Investigational Site
Barcelona , 08916, Spain
Alkermes Investigational Site
Madrid , 28905, Spain
Alkermes Investigational Site
Santa Cruz de Tenerife , 38010, Spain
Alkermes Investigational Site
Dnipro , 49005, Ukraine
Alkermes Investigational Site
Ivano-Frankivsk , 76008, Ukraine
Alkermes Investigational Site
Kharkiv , 61068, Ukraine
Alkermes Investigational Site
Kharkiv , 61103, Ukraine
Alkermes Investigational Site
Lviv , 79000, Ukraine
Alkermes Investigational Site
Odessa , 65025, Ukraine
Alkermes Investigational Site
Zaporizhzhya , 69035, Ukraine
Alkermes Investigational Site
Zaporizhzhya , 69600, Ukraine

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Phase:

Phase 3

Estimated Enrollment:

1057

Study ID:

NCT02634307

Recruitment Status:

Completed

Sponsor:


Biogen

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider